OTCMKTS:ERFSF

Eurofins Scientific Stock Forecast, Price & News

$107.50

+0.70 (+0.66 %)

(As of 04/16/2021 12:00 AM ET)

Add

Compare

Today's Range

$104.00

Now: $107.50▼

$107.50

50-Day Range

$87.60

MA: $95.96▼

$106.80

52-Week Range

$48.50

Now: $107.50▼

$107.00

Volume332 shs

Average Volume1,136 shs

Market Capitalization$19.14 billion

P/E Ratio47.57

Dividend YieldN/A

Beta0.82

Eurofins Scientific SE, through its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agro science, agro testing, biopharma, contract development and manufacturing organization, clinical diagnostics, consumer product testing, digital testing, electrical and electronics, environment testing, food and feed testing, forensic, genomic, industrial, materials and engineering, medical device, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Private households

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:ERFSF

Previous SymbolNASDAQ:ERFSF

CUSIPN/A

CIKN/A

Webwww.eurofins.com

Phone32-2766-1620

Employees51,516

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.84

Current Ratio1.36

Quick Ratio1.28

Price-To-Earnings

Trailing P/E Ratio47.57

Forward P/E Ratio30.28

P/E GrowthN/A

Sales & Book Value

Annual Sales$5.19 billion

Price / Sales3.69

Cash Flow$5.58 per share

Price / Cash Flow19.25

Book Value$18.24 per share

Price / Book5.89

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares178,000,000

Market Cap$19.14 billion

Next Earnings DateN/A

OptionableNot Optionable

Headlines

Eurofins Scientific SE (OTCMKTS:ERFSF) Receives Average Recommendation of "Buy" from Analysts
April 17, 2021 | americanbankingnews.com

Eurofins Scientific (OTCMKTS:ERFSF) Sets New 52-Week High at $107.00
April 15, 2021 | americanbankingnews.com

Eurofins Scientific (OTCMKTS:ERFSF) Sets New 52-Week High at $106.10
April 8, 2021 | americanbankingnews.com

Eurofins Scientific (OTCMKTS:ERFSF) Hits New 12-Month High at $105.92
April 1, 2021 | americanbankingnews.com

Eurofins Technologies Launches an Enhanced Variant of Concern-Discriminating PCR Test Including the South African Variant (B.1.351)
March 22, 2021 | finance.yahoo.com

Eurofins Adds Virus Variant Detection to its SARS-CoV-2 Monitoring Solution for Wastewater, Surface, Air and Worn Masks
March 12, 2021 | finance.yahoo.com

Eurofins Launches empowerDX COVID-19 Home Collection Kit on Amazon
March 10, 2021 | finance.yahoo.com

Nation’s PFAS Leader, Eurofins, Expands Reporting to 75 Compounds
March 1, 2021 | finance.yahoo.com

Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise
February 18, 2021 | finance.yahoo.com

Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines
February 11, 2021 | finance.yahoo.com

Eurofins Donates 100,000 Fast PCR Tests to Detect SARS-CoV-2 Variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B.1.1.248 (ex. Brazil) to Hospitals Around the World
February 2, 2021 | finance.yahoo.com

Eurofins Offers a New Molecular Solution to Detect SARS-CoV-2 variants B.1.1.7 (UK) and B.1.351 (South Africa)
January 28, 2021 | finance.yahoo.com

Eurofins Q4 Organic Revenue Climbs; Says Outlook Remains Strong For 2021, Beyond
January 25, 2021 | nasdaq.com

Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations
December 28, 2020 | finance.yahoo.com

News for Eurofins Scientific SE
December 23, 2020 | markets.businessinsider.com

Eurofins Launches COVID-19 PCR Tests With At-Home Self-Sampling Options in Europe and Donates Sequencing Capacity to Identify VUI-2020-12/01 Strain Reported to Spread Faster in the UK
December 22, 2020 | finance.yahoo.com

Eurofins Raises Its 2020 Objectives After Strong Momentum in Its Core Business, as Well as in COVID-19 Related Activities in October and November
December 15, 2020 | finance.yahoo.com

Eurofins Technologies Launches New and Improved Lateral Flow Device Product Line for Allergen Detection in Foodstuffs and Environmental Samples
December 14, 2020 | finance.yahoo.com

Eurofins Launches a Rapid SARS-CoV-2 Antigen Test and a RT-PCR Test in a Self-Sampled, Gargling Format
December 14, 2020 | finance.yahoo.com

EAG Laboratories Announces Latest Advancement in Transmission Electron Microscopy
December 9, 2020 | finance.yahoo.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.88 out of 5 stars

Medical Sector

1146th out of 2,024 stocks

Private Households Industry

171st out of 378 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Eurofins Scientific.

2.5 Community Rank

Outperform Votes
Eurofins Scientific has received 152 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Eurofins Scientific has received 155 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Eurofins Scientific has received 50.49% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Eurofins Scientific and other stocks. Vote “Outperform” if you believe ERFSF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ERFSF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Eurofins Scientific does not currently pay a dividend.
Dividend Growth
Eurofins Scientific does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Eurofins Scientific insiders have not sold or bought any company stock.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Eurofins Scientific are expected to grow by 21.69% in the coming year, from $3.55 to $4.32 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Eurofins Scientific is 47.57, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.03.
Price to Earnings Ratio vs. Sector
The P/E ratio of Eurofins Scientific is 47.57, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 45.43.
Price to Book Value per Share Ratio
Eurofins Scientific has a P/B Ratio of 5.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

$107.50

+0.70 (+0.66 %)

(As of 04/16/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ERFSF News and Ratings via Email

Sign-up to receive the latest news and ratings for ERFSF and its competitors with MarketBeat's FREE daily newsletter.

Eurofins Scientific (OTCMKTS:ERFSF) Frequently Asked Questions

Is Eurofins Scientific a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last year. There are currently 2 sell ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Eurofins Scientific stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERFSF, but not buy additional shares or sell existing shares.
View analyst ratings for Eurofins Scientific or view top-rated stocks.

What stocks does MarketBeat like better than Eurofins Scientific?

Wall Street analysts have given Eurofins Scientific a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eurofins Scientific wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Eurofins Scientific's stock been impacted by Coronavirus?

Eurofins Scientific's stock was trading at $495.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ERFSF stock has decreased by 78.3% and is now trading at $107.50.
View which stocks have been most impacted by COVID-19.

Who are Eurofins Scientific's key executives?

Eurofins Scientific's management team includes the following people:

Dr. Gilles G. Martin, Chairman & CEO (Age 58)
Ms. Valerie Hanote, Exec. Director (Age 55)
Dr. Yves-LoÃ¯c Martin, Exec. Director (Age 55)
Mr. Laurent Lebras, Group Admin. & Fin. Director
Mr. Dirk Bontridder, Group Exec. VP of Pres Pharmaceutical Services & Member of Management Board (Age 48)
Dr. Markus Brandmeier, Group Exec. VP of Food Testing & Member of The Exec. Board (Age 57)

Who are some of Eurofins Scientific's key competitors?

Some companies that are related to Eurofins Scientific include EssilorLuxottica Société anonyme (ESLOY), Shin-Etsu Chemical (SHECY), KDDI (KDDIY), Deutsche Post (DPSGY), Bayerische Motoren Werke Aktiengesellschaft (BAMXF), Vinci (VCISY), Daikin Industries,Ltd. (DKILY), Pjsc Lukoil (LUKOY), DENSO (DNZOY), A.P. Møller - Mærsk A/S (AMKBY), Oriental Land (OLCLY), ITOCHU (ITOCY), Jardine Matheson (JMHLY), HOYA (HOCPY) and Sun Hung Kai Properties (SUHJY).
View all of ERFSF's competitors.

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $107.50.

How much money does Eurofins Scientific make?

Eurofins Scientific has a market capitalization of $19.14 billion and generates $5.19 billion in revenue each year. The company earns $218.74 million in net income (profit) each year or $2.26 on an earnings per share basis.

How many employees does Eurofins Scientific have?

Eurofins Scientific employs 51,516 workers across the globe.

What is Eurofins Scientific's official website?

The official website for Eurofins Scientific is www.eurofins.com.

Where are Eurofins Scientific's headquarters?

Eurofins Scientific is headquartered at 23 Val Fleuri, Luxembourg N4, 1526.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The company can be reached via phone at 32-2766-1620 or via email at [email protected]

This page was last updated on 4/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here